These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 11398841)

  • 21. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebellar cortical tau pathology in progressive supranuclear palsy and corticobasal degeneration.
    Piao YS; Hayashi S; Wakabayashi K; Kakita A; Aida I; Yamada M; Takahashi H
    Acta Neuropathol; 2002 May; 103(5):469-74. PubMed ID: 11935262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy.
    Urakami K; Mori M; Wada K; Kowa H; Takeshima T; Arai H; Sasaki H; Kanai M; Shoji M; Ikemoto K; Morimatsu M; Hikasa C; Nakashima K
    Neurosci Lett; 1999 Jan; 259(2):127-9. PubMed ID: 10025574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Features of Patients With Nonfluent/Agrammatic Primary Progressive Aphasia With Underlying Progressive Supranuclear Palsy Pathology or Corticobasal Degeneration.
    Santos-Santos MA; Mandelli ML; Binney RJ; Ogar J; Wilson SM; Henry ML; Hubbard HI; Meese M; Attygalle S; Rosenberg L; Pakvasa M; Trojanowski JQ; Grinberg LT; Rosen H; Boxer AL; Miller BL; Seeley WW; Gorno-Tempini ML
    JAMA Neurol; 2016 Jun; 73(6):733-42. PubMed ID: 27111692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Corticobasal degeneration and atypical progressive supranuclear palsy: their symptomatology, laboratory examination and differential diagnosis].
    Morimatsu M; Negoro K; Mori H
    Rinsho Shinkeigaku; 2004 Nov; 44(11):982-5. PubMed ID: 15651349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations of mitochondrial genomic variation with corticobasal degeneration, progressive supranuclear palsy, and neuropathological tau measures.
    Valentino RR; Tamvaka N; Heckman MG; Johnson PW; Soto-Beasley AI; Walton RL; Koga S; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
    Acta Neuropathol Commun; 2020 Sep; 8(1):162. PubMed ID: 32943110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct subcortical tau burden: The tau pallido-claustral ratio separates progressive supranuclear palsy and corticobasal degeneration.
    Zhao CS; Yan L; He W; Ang LC; Zhang Q
    Brain Pathol; 2022 Mar; 32(2):e13030. PubMed ID: 34672063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy.
    Urakami K; Wada K; Arai H; Sasaki H; Kanai M; Shoji M; Ishizu H; Kashihara K; Yamamoto M; Tsuchiya-Ikemoto K; Morimatsu M; Takashima H; Nakagawa M; Kurokawa K; Maruyama H; Kaseda Y; Nakamura S; Hasegawa K; Oono H; Hikasa C; Ikeda K; Yamagata K; Wakutani Y; Takeshima T; Nakashima K
    J Neurol Sci; 2001 Jan; 183(1):95-8. PubMed ID: 11166802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological comparison between corticobasal degeneration and progressive supranuclear palsy.
    Takeda M; Tachibana H; Okuda B; Kawabata K; Sugita M
    Clin Neurol Neurosurg; 1998 Jun; 100(2):94-8. PubMed ID: 9746295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms.
    Sergeant N; Wattez A; Delacourte A
    J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
    Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
    Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholinergic neuronal loss in the basal forebrain and mesopontine tegmentum of progressive supranuclear palsy and corticobasal degeneration.
    Kasashima S; Oda Y
    Acta Neuropathol; 2003 Feb; 105(2):117-24. PubMed ID: 12536222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates.
    Ling H; Gelpi E; Davey K; Jaunmuktane Z; Mok KY; Jabbari E; Simone R; R'Bibo L; Brandner S; Ellis MJ; Attems J; Mann D; Halliday GM; Al-Sarraj S; Hedreen J; Ironside JW; Kovacs GG; Kovari E; Love S; Vonsattel JPG; Allinson KSJ; Hansen D; Bradshaw T; Setó-Salvia N; Wray S; de Silva R; Morris HR; Warner TT; Hardy J; Holton JL; Revesz T
    Acta Neuropathol; 2020 Apr; 139(4):717-734. PubMed ID: 31950334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?
    Sha S; Hou C; Viskontas IV; Miller BL
    Nat Clin Pract Neurol; 2006 Dec; 2(12):658-65. PubMed ID: 17117169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration.
    Arai T; Ikeda K; Akiyama H; Nonaka T; Hasegawa M; Ishiguro K; Iritani S; Tsuchiya K; Iseki E; Yagishita S; Oda T; Mochizuki A
    Ann Neurol; 2004 Jan; 55(1):72-9. PubMed ID: 14705114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Corticobasal degeneration with olivopontocerebellar atrophy and TDP-43 pathology: an unusual clinicopathologic variant of CBD.
    Kouri N; Oshima K; Takahashi M; Murray ME; Ahmed Z; Parisi JE; Yen SH; Dickson DW
    Acta Neuropathol; 2013 May; 125(5):741-52. PubMed ID: 23371366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progressive supranuclear palsy with dementia: cortical pathology.
    Bigio EH; Brown DF; White CL
    J Neuropathol Exp Neurol; 1999 Apr; 58(4):359-64. PubMed ID: 10218631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.